Phase
Condition
Anorexia
Treatment
Olanzapine 5 MG
Placebo
Olanzapine 2.5 MG
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
pathologically or cytologically metastatic or locally advanced cancer
anorexia and >=5% weight loss during the past 6 months or anorexia with numericalscale of anorexia >=5
ECOG performance status 0-3
able to complete questionaire and able to swallow pills
Exclusion
Exclusion Criteria:
receiving chemotherapy or anti-cancer systemic therapy
life expectancy longer than 1 month
received radiotherapy at head/neck or thoracic or upper abdomen in the past 2 weeks
surgery within 4 weeks
pregnancy
serum bilirubin > 2 mg/dl or serum Cr > 2 mg/dl
current use of olanzapine or other antipsychotic drug
known cardiac arrhythmia, uncontrolled brain metastasis, history of seizure or acutecoronary event in the past 6 months
Study Design
Connect with a study center
Division of medical oncology, department of medicine Siriraj Hospital
Bangkok, 10700
ThailandActive - Recruiting
Faculty of Medicine Siriraj Hospital
Bangkok, 10260
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.